These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 15246098

  • 1. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H, Kubota T, Itani H, Minami K, Miwa H, Nishitani Y.
    Bioorg Med Chem; 2004 Aug 01; 12(15):4221-31. PubMed ID: 15246098
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T, Iizawa Y, Okonogi K, Miyake A.
    J Antibiot (Tokyo); 2000 Oct 01; 53(10):1053-70. PubMed ID: 11132950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T, Kamiyama K, Matsunaga N, Tawada H, Iizawa Y, Okonogi K, Miyake A.
    J Antibiot (Tokyo); 2000 Oct 01; 53(10):1071-85. PubMed ID: 11132951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.
    Ozden S, Karataş H, Yildiz S, Göker H.
    Arch Pharm (Weinheim); 2004 Oct 01; 337(10):556-62. PubMed ID: 15476288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
    Maruyama T, Yamamoto Y, Kano Y, Kurazono M, Matsuhisa E, Takata H, Takata T, Atsumi K, Iwamatsu K, Shitara E.
    Bioorg Med Chem; 2007 Oct 01; 15(19):6379-87. PubMed ID: 17681767
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines.
    Göker H, Ozden S, Yildiz S, Boykin DW.
    Eur J Med Chem; 2005 Oct 01; 40(10):1062-9. PubMed ID: 15992965
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.